Core Laboratories NV (CLB) — Cash Flow-to-Debt Ratio
Core Laboratories NV (CLB) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of $3.96 Million could theoretically repay 0% of its total liabilities ($312.58 Million) in one year. See CLB free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Core Laboratories NV Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Core Laboratories NV across 31 annual periods. Also explore CLB net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Core Laboratories NV (1995–2025)
Year-by-year debt coverage analysis for Core Laboratories NV. For market capitalisation and broader financial context, see CLB company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $37.18 Million | $317.19 Million | ▼ -30.9% |
| 2024 | 0.17x | $56.39 Million | $332.67 Million | ▲ +143.8% |
| 2023 | 0.07x | $24.79 Million | $356.59 Million | ▲ +8.5% |
| 2022 | 0.06x | $24.96 Million | $389.40 Million | ▼ -26.4% |
| 2021 | 0.09x | $36.58 Million | $419.85 Million | ▼ -25.8% |
| 2020 | 0.12x | $57.87 Million | $493.01 Million | ▼ -22.3% |
| 2019 | 0.15x | $89.53 Million | $592.53 Million | ▼ -34.1% |
| 2018 | 0.23x | $111.83 Million | $487.93 Million | ▼ -19.6% |
| 2017 | 0.28x | $124.27 Million | $436.08 Million | ▼ -9.7% |
| 2016 | 0.32x | $131.89 Million | $417.75 Million | ▼ -6.5% |
| 2015 | 0.34x | $219.10 Million | $648.96 Million | ▼ -35.3% |
| 2014 | 0.52x | $303.45 Million | $581.66 Million | ▼ -14.0% |
| 2013 | 0.61x | $298.14 Million | $491.62 Million | ▲ +14.7% |
| 2012 | 0.53x | $237.20 Million | $448.60 Million | ▲ +9.7% |
| 2011 | 0.48x | $204.13 Million | $423.48 Million | ▼ -19.5% |
| 2010 | 0.60x | $205.83 Million | $343.70 Million | ▲ +23.9% |
| 2009 | 0.48x | $181.87 Million | $376.41 Million | ▲ +17.5% |
| 2008 | 0.41x | $155.21 Million | $377.34 Million | ▲ +44.4% |
| 2007 | 0.28x | $125.69 Million | $441.16 Million | ▲ +1.3% |
| 2006 | 0.28x | $120.31 Million | $427.93 Million | ▼ -32.6% |
| 2005 | 0.42x | $74.78 Million | $179.28 Million | ▲ +51.9% |
| 2004 | 0.27x | $54.20 Million | $197.43 Million | ▼ -9.9% |
| 2003 | 0.30x | $60.88 Million | $199.92 Million | ▲ +20.9% |
| 2002 | 0.25x | $40.98 Million | $162.66 Million | ▲ +45.1% |
| 2001 | 0.17x | $28.32 Million | $163.08 Million | ▲ +274.8% |
| 2000 | 0.05x | $7.27 Million | $156.86 Million | ▲ +55.4% |
| 1999 | 0.03x | $4.50 Million | $150.90 Million | ▼ -32.0% |
| 1998 | 0.04x | $6.60 Million | $150.50 Million | ▲ +383.2% |
| 1997 | -0.02x | $-1.90 Million | $122.70 Million | ▼ -105.6% |
| 1996 | 0.27x | $8.80 Million | $32.10 Million | ▲ +0.0% |
| 1995 | 0.27x | $7.70 Million | $28.10 Million | — |